pharmaphorum

JANUARY 9, 2023

is to acquire the 2015-established Amryt Pharma Plc. The post Chiesi expands rare disease portfolio with Amryt Pharma acquisition appeared first on. Biopharma and healthcare group Chiesi Farmaceutici S.p.A. in an all-cash transaction at $14.50 per American Depositary Share (ADS). Each ADS represents five Amryt ordinary shares.

Pharma 80

Pharma Biopharma Medicine Management 80

European Pharmaceutical Review

AUGUST 23, 2022

However, the researchers noted that a larger number of warning letters were issued to pharmaceutical manufacturers (ie, by CDER) than to medical device manufacturers (by CDRH) between 2015 and 2020. The post Common pharma compliance concerns cited by FDA warning letters appeared first on European Pharmaceutical Review.

FDA 94

FDA Food and Drug Administration Pharma Pharmaceutical manufacturing 94

European Pharmaceutical Review

OCTOBER 5, 2022

According to the survey, apprentice numbers are three times higher than 2015 statistics, across all skill levels from those entering the industry to master-qualified individuals. Pharmaceutical companies who contributed to the survey include AbbVie, AstraZeneca, Boehringer Ingelheim and GSK.

Pharma 87

Pharma Training Networking Doctors 87

MedCity News

JANUARY 9, 2024

Though GSK divested much of its oncology assets to Novartis in 2015, the company has built it back through a internal R&D and business development deals. GSK Senior Vice President, Global Head of Oncology, R&D Hesham Abdullah explained the company’s evolving cancer strategy in an interview during the J.P.

Healthcare 117

Healthcare Healthcare Biopharma Pharma 117

pharmaphorum

DECEMBER 22, 2022

The collaboration comes as the pharma industry is increasingly having to face up to its impact on the environment, after years of avoiding scrutiny of its impact as a major manufacturer of goods. ” They also hope to recruit other companies to the collaboration in order to broaden its impact.

Pharma 90

Pharma Manufacturing Recruitment Pharmaceutical 90

pharmaphorum

NOVEMBER 11, 2022

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from ?eyda This resulted in a change in career path towards pharma, beginning with a role as a marketing professional at Baxter. The post Spotlight on women in pharma: ?eyda eyda Atadan Memi?, eyda Atadan Memi?,

Pharma 84

Pharma Medicine Marketing Management 84

World of DTC Marketing

OCTOBER 6, 2021

The Defense Threat Reduction Agency, a division of the Department of Defense, provided more than $10 million of funding in 2013 and 2015 to Emory University, as research done by the nonprofit Knowledge Ecology International has revealed. million for CDC’s preclinical research; $39.7 million for DOD’s preclinical research; $11.9

Food and Drug Administration 198

Food and Drug Administration Government Medicine Food 198

Eversana Intouch

OCTOBER 13, 2023

August 2015. Accessed July 5, 2023. link] Graham G, Ostrowski M, Sabina A. Defeating the ZIP Code health paradigm: data, technology, and collaboration are key. Health Affairs website. Accessed July 5, 2023. link] Essien UR, Kornej J, Johnson AE, et al. Social determinants of atrial fibrillation. Nat Rev Cardiol. 2021;18(11):763-773.

Pharma 87

Pharma Education Government Pharmaceutical 87

World of DTC Marketing

JANUARY 4, 2022

billion in 2015 and $208.9 Pharma companies are aware that insurers will rarely say no to new cancer therapies, but increased scrutinization of early approvals is on the horizon. Newly approved cancer drugs cost an average of $10,000 per month, with some as high as $30,000 per month. Just over a decade ago, the standard was $4,500.

Insurance 273

Insurance Transportation Medical Prescription 273

World of DTC Marketing

MAY 4, 2022

A 2015 Commonwealth Fund brie f showed that — before the major provisions of the Affordable Care Act were introduced — the United States had worse outcomes and spent more on health care, primarily because of greater use of medical technology and higher prices, compared to other high-income countries. This IS the future of healthcare.

Healthcare 210

Healthcare Healthcare Doctors Insurance 210

pharmaphorum

JULY 8, 2022

The number of AI-based drug discovery strategic alliances has increased significantly, from just 10 in 2015 to 105 in 2021, with companies like BenevolentAI, Exscientia and Insilico Medicine featuring prominently in the dealmaking.

Marketing 122

Marketing Pharma Education Medicine 122

Contrarian Sales Techniques

JANUARY 25, 2023

Martin Shkreli, also known as "Pharma Bro," is a former pharmaceutical executive who came to public attention in 2015 when his company, Turing Pharmaceuticals, raised the price of a life-saving drug called Daraprim by more than 5,000%.

Sales 52

Sales Pharma Distribution Pharmaceutical 52

Pharmaceutical Technology

JULY 21, 2022

The pharma industry has deeply rooted environmental, social, and governance (ESG) issues that challenge sustainability. Pharma and medical device companies are implementing AI to transform supply chains and better manage their operations. Artificial intelligence (AI). 3D printing.

Food and Drug Administration 98

Food and Drug Administration Government Pharma Healthcare 98

pharmaphorum

JANUARY 10, 2023

As two in five pharma leaders say that moving to a consumer-first mindset is a priority for the next two years, digital customer experience agency Graphite Digital is to publish a special edition of its Contradiction Conundrum whitepaper report, released in partnership with Reuters Events Pharma last year.

Pharma 52

Pharma Specialization Sales Biopharma 52

pharmaphorum

DECEMBER 29, 2022

The complaint claims that Par agreed not to launch its generic, in return for Novartis not launching a patent infringement suit and agreeing not to launch its own authorised generic of the drug until 30 March, 2015, giving Par a valuable six months to sell its generic unopposed in the market.

Retail 52

Retail Marketing Government Doctors 52

pharmaphorum

OCTOBER 6, 2022

Fresh with a new brand identity, the France-headquartered pharma group has pledged to grow its oncology sales from its current objective of €1 billion in 2025 to €3 billion in 2030, continuing a diversification of its business from its traditional focus on cardiovascular diseases. billion and $1.8 billion and $1.8

Sales 82

Sales Pharma Government Medicine 82

Pharmaceutical Technology

MAY 10, 2023

The CDC had applied for patents back in 2006, and was later granted four in 2015. According to a consensus forecast from GlobalData’s Pharma Intelligence Centre, Descovy is estimated to yield $1.83 The November 2019 lawsuit marked a further escalation in an existing dispute.

Government 105

Government FDA Pharmaceutical Pharma 105

World of DTC Marketing

AUGUST 21, 2020

. “Obesity is a serious global problem, and the suboptimal vaccine-induced immune responses observed in the obese population cannot be ignored,” pleaded researchers from the Mayo Clinic’s Vaccine Research Group in a 2015 study published in the journal Vaccine. And it’s getting worse.

Insurance 238

Insurance Physicians Healthcare Healthcare 238

European Pharmaceutical Review

NOVEMBER 22, 2022

a China-based pharma company has announced it has received clearance for its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to initiate clinical studies of T21, a 3D-printed medicine that can target specific segments in the colon to more safely deliver oral ulcerative colitis (UC) drugs.

Food and Drug Administration 106

Food and Drug Administration Side effects FDA Medicine 106

Pharma Pathway

JANUARY 6, 2023

is a Private incorporated on 24 July 2015. Walk-Ins for Quality Control/ Production/ Production Documentation/ EHS On 7th Jan’ 2023. Job Description. Dasami Lab Pvt. It is classified as Non-govt. Company and registered at Register of Companies, Hyderabad.

Manufacturing 83

Manufacturing Leads Pharma 83

pharmaphorum

OCTOBER 31, 2022

The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen. The post Verge Genomics takes AI-sourced drug for ALS into clinic appeared first on.

Pharma 124

Pharma Leads Medicine Marketing 124

pharmaphorum

NOVEMBER 25, 2022

The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea’s Hanmi Pharma, which originally developed the drug. Spectrum licensed worldwide rights to poziotinib – excluding Korea and China – from Hanmi in back in 2015.

FDA 93

FDA Side effects Prescription Recruitment 93

European Pharmaceutical Review

OCTOBER 7, 2022

In the years 2015 and 2020, clinical-stage cancer programmes increased by a considerable 77 percent (1,642 to 2,911), resulting in a quarter of drugs currently in development worldwide being highly potent. Operating in the market with very low prices have aided China and India to control the OSD CMO market.

Manufacturing 86

Manufacturing Marketing Side effects Transportation 86

pharmaphorum

NOVEMBER 23, 2022

The Japanese pharma said it has filed for approval of TAK-003 with the FDA for the prevention of dengue disease caused by any dengue virus serotype in individuals aged four through 60. The vaccine has already been approved as Qdenga in Indonesia – where the disease is endemic – to protect people in the six to 45 age bracket.

FDA 119

FDA Marketing Leads Safety 119

European Pharmaceutical Review

AUGUST 8, 2022

125 million to be paid by Astellas Pharma US and Amgen Inc for illegally paying the Medicare co-pays for their own products, announced in 2019, and. million) in 2015 , also for knowingly underpaying Medicaid rebates. agreements with AstraZeneca ($46.5 million) and Cephalon ($7.5

Manufacturing 90

Manufacturing Pharmaceutical Pharma Leads 90

Impetus Digital

MARCH 15, 2024

Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).

Recruitment 94

Recruitment Healthcare Provider Patients Healthcare 94

Pharmaceutical Technology

FEBRUARY 22, 2023

The patent battle between Amgen and Sanofi over their cholesterol-lowering antibodies has divided big pharma in the past months. The legal dispute is centered around rival cholesterol-lowering drugs produced by the two companies, which were approved in the summer of 2015. Amgen’s Repatha was greenlit a month later.

Pharma 104

Pharma Government FDA Sales 104

pharmaphorum

AUGUST 17, 2022

It’s part of a larger trend of big pharmas hedging their bets with partnerships with AI firms to find more drug candidates faster. A recent report from GlobalData predicted that pharma spending on AI drug discovery would hit $3 billion in 2025. In 2019 they struck a major deal with China’s Hansoh pharmaceuticals. “At

Medicine 74

Medicine Pharma Engineering Sales 74

PM360

JANUARY 25, 2023

Spurred into action by the pandemic, many pharma brands are undertaking or accelerating their digital transformations. As a relative newcomer to pharma (I joined the industry in 2019), several things stand out about the industry’s approach to digital. There are a few key differences in pharma that made this happen.

Media 96

Media Digital Media Marketing Pharma 96

European Pharmaceutical Review

APRIL 11, 2024

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available.

Manufacturing 96

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 96

European Pharmaceutical Review

MAY 29, 2023

In the paper, the authors predicted that “… implementation [of continuous processing and robotics] in the pharma field should cause a big change, probably within the next five years.” Despite this, only 13 nanomedicines had been approved by the US Food and Drug Administration (FDA) before 2015. Tanzini et al.

Food and Drug Administration 74

Food and Drug Administration Manufacturing Pharma Pharmaceutical 74

pharmaphorum

OCTOBER 17, 2022

9,187,405, granted in 2015, which comes to an end in 2027. HEC Pharma is the only company still challenging the patent, as Novartis previously settled litigation with other generics developers, allowing them to launch on an agreed date prior to that date. HEC Pharma has argued in court that Novartis makes $3.8

Competition 52

Competition Marketing Pharma Sales 52

European Pharmaceutical Review

JANUARY 24, 2023

This will help to maximise on cross-selling opportunities, providing a seamless and customer-centric experience to Velocity’s pharma and CRO partners. At Parexel, Sandra held roles in Phase I project management and business development, before being promoted to a senior portfolio director in 2015.

Key account management 95

Key account management Physicians Networking Management 95

Pharma Marketing Network

APRIL 12, 2021

Tune in and listen to the Pharma Marketing Network and fellow thought leaders from, ROI Marketplace, MedThink, and Sharecare.com, discuss their learnings and insights on native advertising from each of their respective vantage points – pharma-marketer, publisher, and agency. . Released in 2015, R.J. Title Company Email *.

Media 69

Media Digital Media Networking Pharma 69

InCrowd

DECEMBER 14, 2022

I’d been in healthcare most of my career but not specifically pharma or market research. I joined in 2015 and have never looked back. I was first drawn to InCrowd inspired by the impact its work had on creating life-changing therapies.

Marketing 59

Marketing Pharma Sales Healthcare 59

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Congress Coverage.

Media 79

Media Healthcare Healthcare Education 79

European Pharmaceutical Review

APRIL 27, 2023

The pharma company’s current CEO and Chairman of the Board Dr Giovanni Caforio will retire on November 1 2023. Christopher Boerner’s career trajectory Having worked for BMS since February 2015, Boerner has led the worldwide Commercial and Medical organisations. Dr Caforio will continue as Executive Chairman of the Board.

Medicine 72

Medicine Marketing Government Leads 72